News

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}
Welcome to our Corporate client solution

Here you can administrate your corporate solutions users.
Welcome to your subscription for Life Science Focus
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Focus.

Click here to go to sign-up

Advertisement

Advertisement

Medtech

UK ends uncertainty over CE marking for medical devices

Spago plans stock market exit to facilitate fundraising

Pfizer job cuts reported at several manufacturing sites

Medtech

Inossia raises SEK 88m – targets US approval

Moderna plunged by double digits after study data leaked

Advertisement

EQT leads €9.6bn buyout of Qiagen

AstraZeneca wins new FDA approval for serious kidney disease

Column

Anna Rennermalm: Are we hiring the best candidate – or the best AI user?

In Focus

How GLP-1 drugs are changing what we buy at the supermarket

Sponsored content News from our members

OEM Automatic AB

Smartare kvalitetskontroll med Zebra NS42 från OEM Automatic

OEM Automatic AB

Effektiv flödesmätning för vatten- och avloppssystem med FLUXUS WD

Aurevia

QAdvis & Scandinavian CRO are now Aurevia

KNF Neuberger AB

Pumphuvudkonfiguration: Optimera flöde och vakuumprestanda

Aurevia

From innovation to compliance: Medtech Compliance Forum by Aurevia & RAPS explores health technology

Aurevia

Integrated Clinical and Regulatory Support for Oncology Trials

Carl Zeiss AB

Explore the ZEISS Innovation Summit 2026

Aurevia

Your UKRP Partner for Medical Device Market Access in the UK

OEM Automatic AB

Kostnadseffektiv och driftsäker nivåmätning med Rosemount 1208

Aurevia

Medical Device Software Process Design: Why IEC 62304 Matters

Danish Export Association

WHX Dubai 2027: Meet New Customers in the MENA Region

OEM Automatic AB

Kostnadseffektiv automation för framtidens företag

See all announcements

Sponsored content

”Cybersecurity Is Patient Safety”

Advertisement

Major spin-off: Abbott plans to separate nutrition business

AstraZeneca's labor ward drug withdrawal is due to lack of commercial viability

Interview

Study finds key gut bacterium undetectable in one in three Swedish infants

Advertisement

People & Careers

Sciety appoints Thomas Eldered as senior advisor

Interview

Swedish firm makes progress on antiviral treatment

Advertisement

New hair loss pill delivers positive Phase 3 results

Advertisement

Advertisement

Interview

Denmark a leader in EU clinical trials: “We should never accept unnecessary delays”

In Focus

GLP-1 drugs spark unexpected interest among perfume giants

Roche doubles down on Chinese biotech in deal worth up to $15 billion

Advertisement

Saniona moves depression drug closer to first-in-human trial

Ascendis’ weekly achondroplasia treatment recommended for EU approval

Interview

Ulf Landegren: From scientific discovery to successful companies

Advertisement

Former Novo Nordisk CEO nominated as Lundbeck chair

Advertisement

Yes please, I would like to receive Life Science Focuss newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Focus Read cookie and data policy.

Advertisement Advertisement

BREAKING

{{ article.headline }}

0.093|